Welcome to the MarketReader Minute.

Below are AI-generated insights on today’s premarket moves, powered by MarketReader technology.

If you find the insights useful, you may subscribe to our new sector-specific newslette or share this on Twitter.

Friday, November 14

Noteworthy macro moves today: Bitcoin -5.0%. Gold -2.8%. Ethereum -4.4%. Noteworthy US mega-cap moves today: Tesla Inc (TSLA) -4.7%. NVIDIA Corp (NVDA) -3.0%. Walmart Inc (WMT) -2.6%. 

Global equity markets are trading lower amid concerns over U.S. interest rate policy and economic data releases following the end of the government shutdown. Investors are reacting to hawkish comments from Federal Reserve officials, which have dampened expectations for a December rate cut and contributed to a sell-off in major indices.

Recent economic data from China has also weighed on market sentiment, with fixed-asset investment dropping more than expected and industrial production growth slowing significantly. This has raised concerns about the sustainability of China's economic recovery, further impacting global market confidence.

In commodity markets, oil prices have risen due to geopolitical tensions following a Ukrainian attack on a Russian oil terminal. Meanwhile, gold and other precious metals have seen significant declines as investors shift towards risk-off assets amid uncertainty in tech valuations and broader economic conditions.

SPDR Gold Shares (GLD) [-2.5%]
SPDR Gold Shares (GLD) is currently down by 2.5%.Social media discussions indicate that GLD remains significantly above its 50-day moving average, in contrast to Bitcoin, which is notably below it. Additionally, silver prices have dropped significantly, reflecting a strong correlation with gold and possibly influencing the movement in GLD. Ongoing uncertainties regarding upcoming economic data and Federal Reserve interest rate decisions are also affecting market sentiment towards precious metals.

Bitcoin (BTC/USD) [-4.2%]
Bitcoin (BTC/USD) is currently experiencing a notable decline, with a daily return drop of approximately 4.2%. The Bybit x Block Scholes Crypto Derivatives Analytics Report highlights a bearish sentiment, marked by a significant decrease in open interest for large-cap perpetual swaps since early October. Additionally, Michael Saylor's company has reported a reduction of around 47,000 Bitcoins from its holdings, now totaling 437,000 coins, although the reasons for this decrease remain unclear. Social media discussions indicate that Bitcoin closed a daily candle below $100,000 for the first time since May and subsequently fell below $98,000. Users noted substantial liquidations totaling $750 million within 24 hours due to these price movements. Furthermore, Bitcoin is now negative for the year and below its 50-week moving average, with concerns about its ability to reach previous all-time highs.

AMAT | -7.4% | -12.7B
Applied Materials Inc | Semiconductor Materials & Equipment
Applied Materials reported its fourth-quarter fiscal year 2025 results on November 13, 2025, revealing a net income of $1.90 billion and revenue of $6.80 billion, a decline from $7.05 billion the previous year. Adjusted earnings per share (EPS) were $2.17, down from $2.32 year-over-year. Despite exceeding some analyst expectations, the company anticipates first-quarter fiscal year 2026 revenue of approximately $6.85 billion and non-GAAP EPS of $2.18, slightly above consensus estimates. The CFO highlighted trade restrictions that limited access to over 20% of the Chinese market in fiscal 2025. Following the earnings report, shares fell by approximately 6% in premarket trading. Social media discussions noted the revenue beat against estimates but raised concerns about semiconductor demand, particularly in China, contributing to the year-over-year revenue decline.

APP | -4.3% | -7.5B
Applovin Corp | Application Software
Applovin Corp's stock has dropped significantly, declining by over 4% since Thursday. Notably, Director Vivas Eduardo sold 150,000 shares recently, with prices ranging from 643.41 to 656.11. This substantial insider selling may raise concerns regarding the company's future performance. Social media discussions highlight expectations of revenue outperformance, driven by enhancements to the Axon platform and growth in the e-commerce sector, which could lead to further upside potential. Despite challenges such as an SEC investigation and short seller allegations, there are positive outlooks for near-term performance. Additionally, Applovin's price movement coincides with a decline in the Invesco QQQ Trust and the Nasdaq 100 Index, reflecting broader market sentiment impacting technology-related assets.

HOOD | -6.4% | -6.4B
Robinhood Markets Inc | Investment Banking & Brokerage
Robinhood Markets, Inc. reported substantial operating metrics for October 2025, with its funded customer base increasing to 27.1 million, reflecting a year-over-year growth of 2.6 million. Total platform assets reached $343 billion, marking a 3% increase from September and a significant rise compared to the previous year. Equity notional trading volumes surged, showing a month-over-month increase of 34% and an annual growth of 153%. Options contracts traded rose by 22% month-over-month, while cryptocurrency trading volumes experienced a remarkable 480% increase year-over-year. Net deposits for October totaled $5.6 billion, with margin balances climbing to $16.5 billion, a notable rise from the prior month. Discussions on social media highlighted these metrics, alongside concerns regarding elevated leverage costs and potential forced liquidations among retail traders. Additionally, Robinhood's CEO noted expectations for continued growth in retail investing.

TSLA | -4.6% | -56.3B
Tesla Inc | Automobile Manufacturers
Tesla Inc. has experienced a notable decline, with its stock price dropping below the $400 mark for the first time since mid-September. This movement aligns with a broader market downturn, as the Nasdaq 100 Index has also decreased significantly. Recent economic indicators from China, including slower industrial production growth and decreased fixed asset investment, have contributed to global investor caution. Additionally, rising oil prices due to geopolitical tensions have added to market volatility. Social media discussions highlight Elon Musk's comments on the potential of Tesla's Optimus robots to address labor shortages in Japan, juxtaposed with reports of increasing dissatisfaction among Tesla owners regarding battery defects and repair delays. Meanwhile, an analyst from Wedbush suggests that Tesla is entering a critical phase concerning its future in artificial intelligence, following the resolution of Musk's compensation package.

NVDA | -3.2% | -141.7B
NVIDIA Corp | Semiconductors
NVIDIA Corp's stock has dropped significantly amid a broader market decline, influenced by negative economic indicators from China, including slower industrial production growth and decreased fixed asset investment. The technology sector is experiencing heightened scrutiny regarding high valuations, with analysts questioning the sustainability of AI-driven investments. Concurrently, NVIDIA faces potential export restrictions to China, as Amazon and Microsoft support the GAIN AI Act. This development may impact NVIDIA's competitive position in the AI processor market. Social media discussions reflect concerns about the upcoming earnings report on November 19, with expectations running high and any disappointment likely to affect market sentiment. Additionally, Wells Fargo raised its price target for NVIDIA, while Blackrock increased its holdings in the company. The Nasdaq 100 Index has also declined, further correlating with NVIDIA's price movement.

BMY | -5.0% | -4.7B
Bristol-Myers Squibb Co | Pharmaceuticals
Bristol-Myers Squibb has announced the discontinuation of the Phase 3 Librexia ACS trial for milvexian, as an interim analysis by the Independent Data Monitoring Committee determined it unlikely to meet its primary efficacy endpoint for patients recovering from acute coronary syndrome. The trial's safety profile remained consistent with previous studies, revealing no new safety concerns. Despite this setback, two other Phase 3 trials within the Librexia program will continue as planned, with topline results anticipated in 2026. Following this announcement, Bristol-Myers Squibb shares have dropped significantly. Conversations on social media echoed this news shortly after it was released during trading hours, highlighting the trial's halt and its implications.

Thank you for spending a minute with us. 

If you have 2 more minutes, watch this demo of the MarketReader Platform: